Abstract: Provided is a novel dilutable delivery systems and propofol microemulsions suitable for intravenous delivery of propofol.

Abstract: Provided is a novel dilutable delivery systems and propofol microemulsions suitable for intravenous delivery of propofol.

Abstract: Reverse hexagonal mesophase (HII) liquid crystals provide multi-component hexagonal systems for use in solubilizing and/or protecting from degradation one or more bio-macromolecule and/or active material, and relates to therapeutic and non-therapeutic applications, such as an oral delivery system, where the mesophase is adapted for oral administration. The present invention provides the formation of mesophase systems of ternary glycerol monooleate (GMO)/water combinations which comprise at least one triglyceride or an equivalent thereof. At least one biomacromolecule or drug is incorporated in the mesophase of a pharmaceutical composition or oral delivery system.

Abstract: Provided are homogeneous liquid systems substantially 1H-NMR inactive and/or devoid of protons and are capable of enhancing the diffusion separation of a mixture, the system is substantially devoid of at least one NMR active nucleus present in the mixture. Further provided are methods of using the homogeneous liquid systems for enhancing the diffusion separation of a mixture and/or generating a diffusion ordered spectrum of a mixture and/or minimizing the peak width in a liquid state diffusion ordered spectrum of a mixture.

Abstract: Reverse hexagonal mesophase (HII) liquid crystals are provided and relating therapeutic and non-therapeutic applications are demonstrated.

Abstract: Provided are homogeneous liquid systems substantially 1H-NMR inactive and/or devoid of protons and are capable of enhancing the diffusion separation of a mixture, the system is substantially devoid of at least one NMR active nucleus present in the mixture. Further provided are methods of using the homogeneous liquid systems for enhancing the diffusion separation of a mixture and/or generating a diffusion ordered spectrum of a mixture and/or minimizing the peak width in a liquid state diffusion ordered spectrum of a mixture.

Abstract: The present invention relates to pharmaceutical compositions in the form of microcmulsions comprising carbamazcpinc and their enhanced permeability and extended release properties. The microcmulsion composition may be an oil based formulation or a oil/aqueous phase mixed formulation.

Abstract: The present invention discloses a nucleating microemulsion comprising nanovehicles, each comprising an amphiphilic shell surrounding a nucleating agent. The microemulsion is suitable for the delivery of the nucleating agents into a thermoplastic polymer, thereby allowing crystallization of the polymer.

Abstract: The present invention relates to nano-sized self-assembled structured concentrates and their use as effective suitable carriers for transferring active components into the human body. The nano-sized self-assembled concentrates are composed of an aqueous phase, an oil phase, a surfactant a co-solvent and co-surfactant. The formed nano-sized self-assembled structured concentrates may be in the form of an aqueous continuous phase, an oil continuous phase or a bicontinuous phase, and may thus be diluted to any desired extent in either oil or water maintaining their structure and the active material comprised within the nano-sized self-assembled structured concentrates.

Abstract: The present invention relates to nano-sized self-assembled structured concentrates and their use as effective suitable carriers for transferring active components into the human body. The nano-sized self-assembled concentrates are composed of an aqueous phase, an oil phase, a surfactant a co-solvent and co-surfactant. The formed nano-sized self-assembled structured concentrates may be in the form of an aqueous continuous phase, an oil continuous phase or a bicontinuous phase, and may thus be diluted to any desired extent in either oil or water maintaining their structure and the active material comprised within the nano-sized self-assembled structured concentrates.

Abstract: An isolated galactomannan having at least 50 repeating units of mannose and galactose in a ration of between 0.5-1.0 and 1.8-1.0, and having a protein content of less than 20 wt. %, a saponin content of less than 5 wt. %, and a lipid content of less than 1 wt. %, which can be used as an active ingredient in nutraceutical and cosmetic products.

Abstract: The present invention relates to lubricous coating compositions comprising as active material natural or synthetic jojoba oil which is optionally partially or completely hydrogenated and/or isomerized, and a solvent or a dispersing system (an organic liquid in which the jojoba oil is immiscible and dispersing agent(s)). The solvent is water or any organic liquid or a mixture of organic liquids that are capable to dissolve molecularly, at least partly, the jojoba oil. The dispersing system comprises jojoba oil immiscible organic liquid(s) together with dispersing agent(s) that enable homogeneous dispersion of the jojoba oil in it. The composition is preferably used for coating a substrate which is selected among polymers or plastics or naturally occurring macromolecules with high hydrophobicity or with low or medium surface energy.

Abstract: The invention provides an aerosol spray reagent for the presumptive identification of cocaine, cocaine salts and phencyclidene comprising cobalt thiocyanate, a polyol, an aliphatic solvent, a nonionic emulsifier and a silicon antifoam agent, as well as providing a multi-reagent test kit for the presumptive identification of cocaine, cocaine salts and phencyclidene comprising a first aerosol spray reagent as defined and a second reagent which produces a color reaction in the presence of trace amounts of a diazotisable amine.